- Home
- IBEX vs PROK Comparison
IBEX vs PROK Comparison
Compare IBEX & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBEX
- PROK
- Stock Information
- Founded
- IBEX 2017
- PROK 2015
- Country
- IBEX United States
- PROK United States
- Employees
- IBEX N/A
- PROK N/A
- Industry
- IBEX EDP Services
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IBEX Technology
- PROK Health Care
- Exchange
- IBEX Nasdaq
- PROK Nasdaq
- Market Cap
- IBEX 386.9M
- PROK 417.1M
- IPO Year
- IBEX 2020
- PROK N/A
- Fundamental
- Price
- IBEX $37.29
- PROK $3.00
- Analyst Decision
- IBEX Hold
- PROK Strong Buy
- Analyst Count
- IBEX 3
- PROK 4
- Target Price
- IBEX $31.00
- PROK $6.25
- AVG Volume (30 Days)
- IBEX 111.1K
- PROK 2.3M
- Earning Date
- IBEX 11-06-2025
- PROK 11-12-2025
- Dividend Yield
- IBEX N/A
- PROK N/A
- EPS Growth
- IBEX 28.02
- PROK N/A
- EPS
- IBEX 2.36
- PROK N/A
- Revenue
- IBEX $558,273,000.00
- PROK $527,000.00
- Revenue This Year
- IBEX $10.15
- PROK $471.74
- Revenue Next Year
- IBEX $5.82
- PROK N/A
- P/E Ratio
- IBEX $15.92
- PROK N/A
- Revenue Growth
- IBEX 9.77
- PROK N/A
- 52 Week Low
- IBEX $17.53
- PROK $0.46
- 52 Week High
- IBEX $42.99
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- IBEX 50.57
- PROK 51.25
- Support Level
- IBEX $36.42
- PROK $2.90
- Resistance Level
- IBEX $38.50
- PROK $3.48
- Average True Range (ATR)
- IBEX 0.88
- PROK 0.23
- MACD
- IBEX -0.12
- PROK -0.03
- Stochastic Oscillator
- IBEX 56.79
- PROK 30.89
About IBEX IBEX Limited
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.